Download Thrombocytopenia - Texas Tech University Health

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Approach to the newborn with
thrombocytopenia
Dr. Lourdes Asiain
Nov 2004
Objectives
Define mild, moderate and severe
thrombocytopenia
 List most common causes for the
condition
 List dysmorphic features assoc with
Thrombocytopenia
 Description and management of
neonatal alloimmune thrombocytopenia

Thrombocytopenia: Definition
Mild
100,000 to 150,000
Moderate
50,000 to 99,000
Severe
Less than 50,000
Thrombocytopenia: Epidemiology
Up to 25 % of infants admitted to NICU
have the condition.
 Mild asymptomatic thrombocytopenia
occurs in 1% healthy term infants
 Severe thrombocytopenia in term infants
rare

Thrombocytopenia
Increased platelet
consumption
Impaired
Megakaryopoiesis
Thrombocytopenia
Thrombocytopenia: assesment
Term or preterm?
 Other medical conditions
 Are there features suggestive of
congenital infection?
 Congenital anomalies/dysmorphism

Differential Diagnosis

Sick Neonates, Preterm infants, other medical
complications.










Hypoxia and acidosis after birth
Chronic hypoxia from placental insufficiency
Hypothermia
Pre-eclampsia
Sepsis
Congenital viral infections (CMV, rubella)
DIC
NEC
Thrombosis
Exchange transfusions
Differential diagnosis

Neonates with physical
abnormalities/dysmorphism
Thrombocytopenia with absent radius Synd
 Fanconi anemia
 Chromosomal disorders (13,18,21, Turner)
 Kasabach-Merritt Syndrome

Differential diagnosis

Healthy-appearing infant
Occult infection
 Maternal autoimmune thrombocytopenia
 Neonatal alloimmun thrombocytopeni
 Amegakaryocytic thrombocytopenia
 Hereditary macrothrombocytopenia
 Wiskott-Aldrich Sydrome

Common causes

Pre-eclampsia






Magnitude usually correlates with severity of HTN
Often have associated neutropenia
Nadir at 3-4 days of life, recovering to normal levels
by day 7-10
Rarely severe thrombocytopenia
Possible etiology is disruption of hematopoietic
progenitor cell commitment to megakaryopoiesis
Assoc conditions from prematurity may exacerbate
condition
Common causes

Bacterial Sepsis

Several mechanisms that include
endothelial damage, immune mediated
destruction, platelet aggregation and
decreased platelet production.
Common causes

Viral infections

Viral neuraminidase causes sialic acid loss
from platelet membranes

Intravascular platelet aggregation

Congenital infections + Splenomegaly
Assoc with Physical abnormalities or
dysmorphism

TAR Syndrome
Autosomic recessive
 Severe thrombocytopenia and skeletal
abnormalities
 Can be associated with congenital heart
disease
 Platelet nadir during first week generally
improve by 1-3 years of age.

TAR Syndrome
Anomalies/Dysmorphism

Fanconi anemia

Aplastic anemia

Thumb anomalies

Anomalies of GU system
Abnormalities/Dysmorphism

Kasabach-Merrit Syndrome
Hemangioma
 Coagulation is activated locally and platelets
are sequestered in the vascular
malformation
 May not be apparent

Maternal autoimmune
Thrombocytopenia
ITP, autoimmune diseases
 Maternal antibodies vs. platelet antigens


Glycoprotein IIb/IIIa and Ib/IX
Antibodies cross placenta and bind to these
antigens on fetal platelets.
 Determine the mother’s platelet count

Neonatal alloimmune
thrombocytopenia
A mother lacks a platelet antogen that
her fetus inherited from father.
 Maternal IgG vs “foreign” antigen on fetal
platelets cross the placenta and destroy
them.
 Most common platelet antigen HPA-1a

Management of immune mediated
Thrombocytopenia

IVIG
In cases of severe thrombocytopenia or
clinical bleeding
 1gram/Kg
 In cases of NAIT Head US and platelet
transfusion with platelets that are free on
HPA1 antigen.

Less common etiologies
Congenital amegakarocitic
thrombocytopenia (AR)
 Heredetary macrothrmbocytopenias (AD)
 Wiskott Aldrich Syndrome (WAS protein X)

Immunedefiency
 Eczema
 Thrombocytopenia

Conclusions
Thrombocytopenia is often encountered
in newborns, specially sick preterm
infants
 Initial assessment should consider
gestational age, co-morbid conditions,
congenital-physical anomalies and
dysmorphism.

Thank You

References
NeoReviews.org: Approach to the Newborn
who has thrombocytopenia. Vol.5 2004
 Curr opinion Obst Gynecol: Platelet
disorders in pregnancy. 2001;13:115-119
 Avery’s Diseases of the Newborn. Taesch
et Ballard.
